Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy evaluation of treatment with amivantamab in patients with recurrent and metastatic adenoid cystic carcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:38.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the inclusion and exclusion criteria for the study. This change provides specific information about the health conditions, prior treatments, and other factors that researchers will consider when selecting participants for the clinical trial.
    Difference
    52%
    Check dated 2024-05-22T21:04:28.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:29:52.000Z thumbnail image

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.